Immunotherapy for metastatic renal cell carcinoma: Treatment with plak cells and low-dose interleukin-2

D. Engelstein, J. Shmueli, O. Kessler, E. Mukamel, B. Nussbaum, H. Hadar, Z. Ossimi, A. Novogrodsky, C. Servadio

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Immunotherapy for metastatic renal cell carcinoma: Treatment with plak cells and low-dose interleukin-2'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology